acceleratediagnostics.com (AXDX) - Revenue and Sales Volume

Under the leadership of Jack Phillips, Accelerate Diagnostics (AXDX) aims to redefine hospital testing standards, a goal supported by the company's sales performance trends. The 0.01 level is recording fresh values, while Pheno platform patents and FDA certifications establish a powerful defensive moat. Meanwhile, the slow pace of equipment deployment limits operating leverage, constraining the potential of the subscription model and the margins on consumables.

Revenue and Sales Volume: Accelerate Diagnostics (AXDX) for 07/04/2022 - 05/24/2025

Analytical breakdowns for Accelerate Diagnostics

- market value and analyst target forecast:

Market Chart Accelerate Diagnostics Inc|AXDX - Analyst Consensus Forecast

- market capitalization indicators:

Market Capitalization Accelerate Diagnostics, Inc.|AXDX - Enterprise Value

- company book value details:

Accounting Value per Share Accelerate Diagnostics|AXDX - Book Capitalization|Market Cap to Net Assets Ratio acceleratediagnostics.com|AXDX - Company Total Assets

- debt and solvency information:

Debt to Capital Accelerate Diagnostics|AXDX - Long-Term Debt to Equity|Short-Term Debt to Equity Accelerate Diagnostics Inc.|AXDX - Company Aggregate Debts|Debts to Book Value Accelerate Diagnostics, Inc.|AXDX - Company Long-Term Debt|Company Short-Term Loans and Borrowings Accelerate Diagnostics|Quick Ratio acceleratediagnostics.com

- company profitability and valuation multiples indicators:

AXDX - Net Income|Future Net Profit Accelerate Diagnostics|AXDX - P/E Multiple|Projected Price to Earnings Ratio acceleratediagnostics.com|AXDX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Accelerate Diagnostics, Inc.|AXDX - Operating profit EBITDA|Earnings per share for the last 12 months Accelerate Diagnostics|AXDX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months acceleratediagnostics.com|AXDX - Earnings growth in current year|Earnings growth forecast for next year Accelerate Diagnostics

- company sales and revenue statistics:

AXDX - Revenue and Sales Volume|Company Sales Forecast Accelerate Diagnostics Inc|AXDX - Price-to-Revenue Ratio|Market Cap to Projected Revenue Accelerate Diagnostics, Inc.

Summary company analysis:AXDX (Accelerate Diagnostics Inc)

Original product of Accelerate Diagnostics Inc.

This indicator measures the aggregate daily cash inflow from product sales, allowing investors to filter out news noise and assess real demand via Accelerate Diagnostics (AXDX) sales statistics on the GURU.Markets platform. The revenue dynamics of Accelerate Diagnostics (AXDX) are critically dependent on geopolitics: while military conflicts stimulate the need for rapid diagnostics, logistical barriers may sharply restrict the export of systems to isolated regions.

Analysis of competing companies